Pharmaceutical Combination
    3.
    发明申请
    Pharmaceutical Combination 审中-公开
    药物组合

    公开(公告)号:US20100063148A1

    公开(公告)日:2010-03-11

    申请号:US12554235

    申请日:2009-09-04

    摘要: A composition of matter comprising in combination as component (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and as component (b) at least one antiepileptic, a pharmaceutical formulation and a dosage form comprising said composition of matter, and a method of treating pain, e.g. neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, whereby component (a) may be administered before or after component (b) and whereby components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.

    摘要翻译: 组合物的组合物,其组合为组分(a)至少一种3-(3-二甲基氨基-1-乙基-2-甲基 - 丙基) - 酚化合物,和组分(b)至少一种抗癫痫剂,药物制剂 以及包含所述物质组合物的剂型,以及治疗疼痛的方法,例如, 其中组分(a)和(b)同时或依次施用于哺乳动物的神经性疼痛,其中组分(a)可以在组分(b)之前或之后施用,由此组分(a)或(b)施用于 哺乳动物通过相同或不同的给药途径。